NYSE:OSTX
OS Therapies Inc
OS Therapies Inc reported net income of −$28.8M in fiscal 2025. Free cash flow was −$14.7M, and the diluted share count rose 320.9%.Summary generated from OS Therapies Inc's SEC filings. Latest annual report filed Mar 31, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equityn/a
Debt / equityn/a
Free cash flow−$14.7M
FCF marginn/a
Share count change+320.9%
Financials
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | n/a | n/a | n/a |
| Operating income | −4 | −7 | −29 |
| Net income | −8 | −9 | −29 |
| Free cash flow | n/a | n/a | −15 |
Recent filings
- 8-KEntry into a material agreement
Oct 5, 2026 - 8-KOther events
Sep 10, 2026 - 8-KDirector or officer change
Sep 9, 2026 - 8-KEntry into a material agreement
Aug 21, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 14, 2026 - 8-KEntry into a material agreement
Aug 12, 2026 - 8-KEntry into a material agreement
Aug 6, 2026 - 8-KTermination of a material agreement
Jul 29, 2026